Former Chief Financial Officer · Wave Life Sciences, Inc. (WVE)

Keith Regnante

A named executive officer of Wave Life Sciences in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,088,067

Salary $362,250Stock awards $607,500

FY2018: $1,691,020

5th of 5 named executive officers at Wave Life Sciences by FY2019 total.

5 named officers on file for Wave Life Sciences, FY2019

Keith Regnante’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • WVE’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Wave Life Sciences’s whole pay program stands against its peers

  • Wave Life Sciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on WVE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 26, 2020 (DEF 14A).

Free

Get Keith Regnante’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Keith Regnante compensation by year

Wave Life Sciences Summary Compensation Table · all 4 fiscal years held
In US dollars, as Wave Life Sciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$120,000$327,400$350,000$362,250
Bonus$0$0$0$0
Stock awards$0$124,915$520,650$607,500
Option awards$1,470,919$159,296$668,510$0
Non-equity incentive$48,300$144,100$142,800$108,675
Pension and deferred compensation$0$0$0$0
All other$331$6,136$9,060$9,642
Total$1,639,550$761,847$1,691,020$1,088,067

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Wave Life Sciences, Inc. DEF 14A filed June 26, 2020, accession 0001193125-20-181069, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Wave Life Sciences, Inc. filed document, accession 0001193125-20-181069. Every figure is read from that document and cited to the page and table it appears in. Filed June 26, 2020.

$1.6M
$762K
$1.7M
$1.1M
FY16
FY17
FY18
FY19
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
PSU40,000$320,600—
RSU13,000$108,203—
RSU9,750$78,146—
RSU2,150$17,232—
Option14,625—$40.05
Option2,509—$29.05
Option20,000—$20.89

Per the Outstanding Equity Awards at Fiscal Year-End table in Wave Life Sciences, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Wave Life Sciences’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Paul BolnoPresident and Chief Executive Officer$3,581,526
Mark BaldryFormer Chief Commercial Officer$1,554,827
Michael PanzaraChief Medical Officer$1,272,002
Chandra VargeeseChief Technology Officer$1,239,522
Keith Regnante · this pageFormer Chief Financial Officer$1,088,067

The full Wave Life Sciences compensation record

free company brief

This page is one person within Wave Life Sciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Wave Life Sciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Wave Life Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Keith Regnante's compensation dossier · One-time report. No refunds.